NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in NeuroPace Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +4 vs. Q2 2023
- Shares held
- 18.1M
- +570.9K (+3.3%) vs. Q2 2023
- Total value
- $175.9M
- +$97.3M (+123.8%) vs. Q2 2023
- New holders
- 5
- 10 more added
- Sold out
- 1
- 5 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NPCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 112 | $422.4M |
| Q1 2026 | 113 | $347.9M |
| Q4 2025 | 100 | $405.9M |
| Q3 2025 | 80 | $267.5M |
| Q2 2025 | 99 | $250.7M |
| Q1 2025 | 90 | $294.1M |
| Q4 2024 | 62 | $233.5M |
| Q3 2024 | 48 | $103.1M |
| Q2 2024 | 51 | $109.1M |
| Q1 2024 | 54 | $176.4M |
| Q4 2023 | 41 | $130.8M |
| Q3 2023 | 25 | $175.9M |
| Q2 2023 | 22 | $78.6M |
| Q1 2023 | 24 | $82.0M |
| Q4 2022 | 24 | $25.9M |
| Q3 2022 | 28 | $68.1M |
| Q2 2022 | 32 | $91.2M |
| Q1 2022 | 40 | $149.5M |
| Q4 2021 | 41 | $181.5M |
| Q3 2021 | 39 | $177.4M |
| Q2 2021 | 44 | $259.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding NeuroPace Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| KCK Ltd. | 5,621,111 | $54.7M | 77.70% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,012,281 | $39.0M | 0.90% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 2,466,205 | $24.0M | 2.42% | −90.0% | Reduced |
| Morgan Stanley | 2,399,716 | $23.3M | 0.00% | +40,850+1.7% | Added |
| Nantahala Capital Management, LLC | 1,219,915 | $11.9M | 1.51% | +795,065+187.1% | Added |
| FMR LLC | 706,245 | $6.87M | 0.00% | −517,418−42.3% | Reduced |
| Kent Lake Capital LLC | 574,417 | $5.59M | 2.18% | +425,212+285.0% | Added |
| Vanguard Group Inc | 386,085 | $3.76M | 0.00% | +7,898+2.1% | Added |
| Millennium Management LLC | 184,169 | $1.79M | 0.00% | −444,764−70.7% | Reduced |
| EAM Investors, LLC | 141,616 | $1.38M | 0.27% | +141,616 | New |
| Geode Capital Management, LLC | 110,209 | $1.07M | 0.00% | +38,694+54.1% | Added |
| Bridgeway Capital Management, LLC | 60,048 | $584.3K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 59,968 | $583.5K | 0.00% | +23,851+66.0% | Added |
| Renaissance Technologies LLC | 44,285 | $431.0K | 0.00% | +26,985+156.0% | Added |
| State Street Corp | 33,251 | $323.5K | 0.00% | +10,800+48.1% | Added |
| Northern Trust Corp | 22,201 | $216.0K | 0.00% | +6,095+37.8% | Added |
| Barclays PLC | 10,839 | $105.5K | 0.00% | +10,721+9,085.6% | Added |
| Financial Advocates Investment Management | 10,000 | $97.3K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 5,500 | $53.5K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2,984 | $29.0K | 0.00% | +2,984 | New |
| Qube Research & Technologies Ltd | 2,399 | $23.3K | 0.00% | +2,399 | New |
| Federated Hermes, Inc. | 424 | $4.13K | 0.00% | +424 | New |
| Wells Fargo & Company | 74 | $720 | 0.00% | −149−66.8% | Reduced |
| UBS Group AG | 55 | $535 | 0.00% | +55 | New |
| Royal Bank of Canada | 4 | $0 | 0.00% | −337−98.8% | Reduced |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| BerganKDV Wealth Management, LLC | – | – | – | – | Not filed |